Welcome Customer !

Membership

Help

Shanghai Shenzhixin Biotechnology Co., Ltd
Custom manufacturer

Main Products:

instrumentb2b>Products

Shanghai Shenzhixin Biotechnology Co., Ltd

  • E-mail

  • Phone

  • Address

    No. B627, Zone B, Changjiang Software Park, 180 Changjiang South Road, Shanghai

Contact Now

Isolation and culture of human peripheral blood endothelial cells

NegotiableUpdate on 05/06
Model
Nature of the Manufacturer
Producers
Product Category
Place of Origin

Overview

Isolation and culture of human peripheral blood endothelial cells: Endothelial progenitor cells are precursor cells of vascular endothelial cells. Under physiological or pathological stimulation, they can be mobilized from bone marrow to peripheral blood to participate in the repair of damaged blood vessels. Research has shown that endothelial progenitor cells play an important role in cardiovascular and cerebrovascular diseases, peripheral vascular diseases, tumor angiogenesis, and wound healing, and provide new ideas for the research and treatment of ischemic diseases.

Product Details

Isolation and culture of endothelial progenitor cells from human peripheral blood

Endothelial progenitor cells are precursor cells of vascular endothelial cells. Under physiological or pathological stimuli, they can be mobilized from bone marrow to peripheral blood to participate in the repair of damaged blood vessels. Research has shown that endothelial progenitor cells play an important role in cardiovascular and cerebrovascular diseases, peripheral vascular diseases, tumor angiogenesis, and wound healing, providing new ideas for the research and treatment of ischemic diseases. Endothelial progenitor cells have migratory characteristics and can further proliferate and differentiate into immature endothelial cells. They lack the characteristic phenotype of mature endothelial cells and cannot form luminal structures. Its main function is to participate in the angiogenesis of ischemic tissue after birth and the repair of vascular injury, making it a hot topic in the study of repair after ischemic disease injury.


Case Show:

人外周血内皮细胞分离培养

人外周血内皮细胞分离培养


Company Profile

Shanghai Shenzhixin Biotechnology Co., Ltd. is an innovative enterprise that provides systematic and high-quality research services for cardiovascular related diseases. It builds a basic medical and clinical translation service system and carries out preclinical CRO services based on pharmacological evaluation, providing various mature cardiovascular disease model animals. . Provide customized animal models, drug screening, pharmacological efficacy evaluation, safety evaluation, pathological analysis, and molecular biology testing services for research institutes, clinical departments, and pharmaceutical enterprises.